| Aug 7 |
Aadi Bioscience GAAP EPS of -$0.54 beats by $0.12, revenue of $6.18M beats by $0.08M
|
| Aug 7 |
Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update
|
| Jul 31 |
Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update
|
| Jul 31 |
We're Keeping An Eye On Aadi Bioscience's (NASDAQ:AADI) Cash Burn Rate
|
| May 29 |
Aadi Bioscience to Participate in the Jefferies Healthcare Conference
|
| May 23 |
Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting
|
